rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Angela Rossetti

Director

Company insider

Files Form 4 as: Director, Aethlon Medical; Director, Palatin Technologies.

In numbers

Trades disclosed
26
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
25 Jun 2014
Last trade
17 Apr 2026
Last filed
15 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
AEMD Aethlon MedicalDirector · Medical Devices · last 17 Apr 20260 buys · 0 sells
PTN Palatin TechnologiesDirector · Biotechnology · last 16 Jun 20200 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Apr 2026filed 15 Oct 2026AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A$50K21,815 at $2.29filing
17 Apr 2026filed 21 Apr 2026AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A$50K21,815 at $2.29filing
17 Apr 2026filed 21 Apr 2026AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A$50K21,815 at $2.29filing
23 Apr 2025filed 25 Apr 2025AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A$50K142,857 at $0.35filing
16 Apr 2024filed 17 Apr 2024AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A$50K32,894 at $1.52filing
28 Apr 2023filed 1 May 2023AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A—116,279 at $0.00filing
15 Sep 2022filed 16 Sep 2022AEMD Aethlon MedicalMedical DevicesSEC FORM 4 Code A—51,370 at $0.00filing
16 Jun 2020filed 18 Jun 2020PTN Palatin Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—127,000 at $0.00filing
16 Jun 2020filed 18 Jun 2020PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code A—73,000 at $0.00filing
24 Jun 2019filed 26 Jun 2019PTN Palatin Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—52,000 at $0.00filing
24 Jun 2019filed 26 Jun 2019PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code A—32,000 at $0.00filing
26 Jun 2018filed 28 Jun 2018PTN Palatin Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
26 Jun 2018filed 28 Jun 2018PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
12 Dec 2017filed 13 Dec 2017PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
12 Dec 2017filed 13 Dec 2017PTN Palatin Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
20 Jun 2017filed 22 Jun 2017PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code A—54,000 at $0.00filing
20 Jun 2017filed 22 Jun 2017PTN Palatin Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—54,000 at $0.00filing
13 Jun 2016filed 13 Jun 2016PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
9 Jun 2016filed 13 Jun 2016PTN Palatin TechnologiesBiotechnologySEC FORM 4 Code A—37,500 at $0.00filing
9 Jun 2016filed 13 Jun 2016PTN Palatin Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—37,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Edward G. BroennimanDirector · Director at Aethlon Medical, filing Form 4 there in the last year
Chetan ShahDirector · Director at Aethlon Medical, filing Form 4 there in the last year
Steven P. LarosaChief Medical Officer · Chief Medical Officer at Aethlon Medical, filing Form 4 there in the last year
Nicolas GikakisDirector · Director at Aethlon Medical, filing Form 4 there in the last year
James B. FrakesCFO/CEO · CFO/CEO at Aethlon Medical, filing Form 4 there in the last year